tiprankstipranks
Trending News
More News >

Aptevo Therapeutics Raises $15.9M to Meet Nasdaq Compliance

Story Highlights
Aptevo Therapeutics Raises $15.9M to Meet Nasdaq Compliance

Don’t Miss TipRanks’ Half-Year Sale

Aptevo Therapeutics ( (APVO) ) just unveiled an announcement.

In response to a compliance issue with Nasdaq Listing Rule 5550(b)(1), Aptevo Therapeutics Inc. successfully raised approximately $15.9 million in equity capital during the quarter ended June 30, 2025. The company conducted multiple equity offerings in April and June 2025, which they believe have brought their stockholders’ equity to at least $2.5 million, thus meeting the Nasdaq requirement. Aptevo is awaiting formal confirmation from Nasdaq regarding their compliance status.

The most recent analyst rating on (APVO) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on Aptevo Therapeutics stock, see the APVO Stock Forecast page.

Spark’s Take on APVO Stock

According to Spark, TipRanks’ AI Analyst, APVO is a Underperform.

Aptevo Therapeutics’ stock score is significantly impacted by its challenging financial performance, marked by declining revenues, high leverage, and negative cash flows. The technical analysis indicates bearish momentum, while the valuation is weakened by persistent losses. However, promising developments in its oncology pipeline offer potential upside if successfully executed.

To see Spark’s full report on APVO stock, click here.

More about Aptevo Therapeutics

Aptevo Therapeutics Inc. operates in the biotechnology industry, focusing on the development of novel oncology and hematology therapeutics. The company is committed to advancing its proprietary ADAPTIR and ADAPTIR-FLEX platform technologies to create innovative therapies for patients with cancer and other life-threatening diseases.

Average Trading Volume: 2,405,687

Technical Sentiment Signal: Strong Sell

Current Market Cap: $8.82M

See more data about APVO stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1